Literature DB >> 14685690

Changes in calpastatin localization and expression during calpain activation: a new mechanism for the regulation of intracellular Ca(2+)-dependent proteolysis.

M Averna1, R De Tullio, P Capini, F Salamino, S Pontremoli, E Melloni.   

Abstract

The amount of calpastatin directly available in cytosol is under the control of [Ca2+] and [cyclic AMP]. Prolonged calpain activation also promotes degradation of calpastatin. The fluctuation of calpastatin concentration in cell soluble fraction is accompanied by an initial decrease in calpastatin gene expression, followed by a fivefold increase in its expression when the inhibitor protein is degraded. This process can be conceptualized as a mechanism to regulate calpastatin availability in the cell. This conclusion is supported by the fact that calpain, the other component of this proteolytic system, undergoes changes in its levels of expression in a much more limited manner. Furthermore, this process can be observed both in cells exposed to different natural stimuli, or in other cell lines. Modification of calpastatin gene expression might represent a new tool for the in vivo control of the regulatory machinery required for the modulation of Ca(2+)-dependent proteolysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14685690     DOI: 10.1007/s00018-003-3288-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  8 in total

Review 1.  Regulation of calpain-2 in neurons: implications for synaptic plasticity.

Authors:  Sohila Zadran; Xiaoning Bi; Michel Baudry
Journal:  Mol Neurobiol       Date:  2010-10-06       Impact factor: 5.590

2.  Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells.

Authors:  The Minh Vo; Rebecca Burchett; Miranda Brun; Elizabeth A Monckton; Ho-Yin Poon; Roseline Godbout
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

3.  The role of chromogranin B in an animal model of multiple sclerosis.

Authors:  Michelle Mo; Ha Thi Hoang; Stefan Schmidt; Robert B Clark; Barbara E Ehrlich
Journal:  Mol Cell Neurosci       Date:  2013-04-24       Impact factor: 4.314

Review 4.  The calpain system and cancer.

Authors:  Sarah J Storr; Neil O Carragher; Margaret C Frame; Tim Parr; Stewart G Martin
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

5.  A positive feedback loop involving nuclear factor IB and calpain 1 suppresses glioblastoma cell migration.

Authors:  The Minh Vo; Saket Jain; Rebecca Burchett; Elizabeth A Monckton; Roseline Godbout
Journal:  J Biol Chem       Date:  2019-07-01       Impact factor: 5.157

6.  Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.

Authors:  Roberto Stifanese; Monica Averna; Roberta De Tullio; Marco Pedrazzi; Francesco Beccaria; Franca Salamino; Marco Milanese; Giambattista Bonanno; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

7.  Modulation by Syk of Bcl-2, calcium and the calpain-calpastatin proteolytic system in human breast cancer cells.

Authors:  Bei Fei; Shuai Yu; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2013-05-16

Review 8.  Nanomedicine strategies for treatment of secondary spinal cord injury.

Authors:  Désirée White-Schenk; Riyi Shi; James F Leary
Journal:  Int J Nanomedicine       Date:  2015-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.